Telehealth for Diabetes Self-Management

Summary

This study will examine the feasibility and short and-long-term efficacy of a web-based telehealth intervention with community-dwelling older adults who have been diagnosed with type 2 diabetes. Effectiveness will be evaluated using multiple measures within three different domains: 1) physical (glycosylated hemoglobin \[HbA1C\], weight, and lipid levels); 2) behavioral (monitoring blood glucose levels, feet inspections, diet, and exercise frequency), and 3) psychosocial (depression, quality of life, social support, and adjustment to diabetes).

This is a randomized controlled trial of a web-based telehealth intervention designed to improve self-management behaviors in a group of community dwelling older diabetics. Two groups of participants will be recruited and randomized over a four-month period during years 01 and 02. Participants in the control group will receive standard diabetic care provided by their provider. Participants in the intervention group will receive computer training in the participant's home in how to access and utilize the web-based telehealth study webpage. The intervention will consist of a program designed and delivered via the Internet to improve the participants' diabetes self-management behaviors using behavioral and motivational strategies and cues to modify perceptions of self-efficacy and beliefs regarding the ability to affect the progress of the disease and change personal behavior.

Conditions

• Diabetes
• Aging

Interventions

BEHAVIORAL

Telehealth for Diabetes Self Management

OTHER

Telehealth for Diabetes Self Management

Web based education format delivered for a six month period

Sponsors & Collaborators

• National Institutes of Health (NIH)

  collaborator NIH

• University of Washington

  lead OTHER

Principal Investigators

• Gail E Bond, Ph.D · University of Washington

• Fredric Wolf, Ph.D · University of Washington

• Martha Price, DNs · University of Washington

• Linda Teri, PhD · University of Washington

• Jerry Palmer · University of Washington

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

60 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2003-09-30

Completion

2007-08-31

Countries

• United States

Study Locations